Skip to main content
Article
Ferric Sulfate Pulpotomy in Primary Teeth with Different Base Materials: A 2-year Randomized Controlled Trial
Quintessence International
  • Burak Aksoy
  • H. Cem Güngör, Marquette University
  • Serdar Uysal, Hacettepe University
  • Cesar Gonzales, Marquette University
  • S. Olmez, Hacettepe University
Document Type
Article
Publication Date
9-16-2022
Publisher
Quintessence Publishing
Original Item ID
DOI: 10.3290/j.qi.b3149429
Disciplines
Abstract

Objective: To evaluate the effects of zinc oxide-eugenol, calcium hydroxide, and mineral trioxide aggregate as base materials on the clinical and radiographic success of ferric sulfate pulpotomies in primary molars.

Method and materials: Following hemostasis with 15.5% ferric sulfate, 105 teeth were randomly allocated to three groups: Group 1, zinc oxide-eugenol; Group 2, calcium hydroxide; and Group 3, mineral trioxide aggregate. All teeth were restored with stainless-steel crowns. Clinical and radiographic examinations were conducted at 6, 12, 18, and 24 months.

Results: After 24 months, clinical success rates for Groups 1 to 3 were 97.1% (34/35 teeth), 94.2% (33/35 teeth), and 97.1% (34/35 teeth), respectively (P > .05). Radiographic success rates were 65.7% (23/35 teeth), 65.7% (23/35 teeth), and 77.1% (27/35 teeth), respectively (P > .05). Internal resorption was the most observed radiographic finding (15/105 teeth).

Conclusions: The choice of zinc oxide-eugenol, calcium hydroxide, and mineral trioxide aggregate, as base materials, did not affect the clinical and radiographic success of ferric sulfate pulpotomies in primary teeth.

Keywords: calcium hydroxide; ferric sulfate; mineral trioxide aggregate; primary teeth; pulpotomy; stainless steel crown; zinc oxide–eugenol.

Comments

Quintessence International, Vol. 16, No. 53 (September 16, 2022): 782-789. DOI.

Citation Information
Burak Aksoy, H. Cem Güngör, Serdar Uysal, Cesar Gonzales, et al.. "Ferric Sulfate Pulpotomy in Primary Teeth with Different Base Materials: A 2-year Randomized Controlled Trial" Quintessence International (2022) ISSN: 0033-6572
Available at: http://works.bepress.com/hcem-gungor/28/